Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by William G. Wierda
Chemoimmunotherapy May Overcome the Adverse Prognostic Significance of 11q Deletion in Previously Untreated Patients With Chronic Lymphocytic Leukemia
Cancer
Cancer Research
Oncology
‹
1
2
Related publications
Profile of Obinutuzumab for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia
OncoTargets and Therapy
Oncology
Pharmacology
Humoral Immune Responses Toward Tumor-Derived Antigens in Previously Untreated Patients With Chronic Lymphocytic Leukemia
Oncotarget
Oncology
DNA Methylation Profiles in Chronic Lymphocytic Leukemia Patients Treated With Chemoimmunotherapy
Clinical Epigenetics
Genetics
Developmental Biology
Molecular Biology
Imatinib Mesylate Therapy May Overcome the Poor Prognostic Significance of Deletions of Derivative Chromosome 9 in Patients With Chronic Myelogenous Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Treatment of Patients With Chronic Lymphocytic Leukemia With 17p Deletion: The Saga Continues
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Disease Burden of Chemotherapy and Chemoimmunotherapy Treatment of Chronic Lymphocytic Leukemia（CLL）Patients in China
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Still a Role for Second-Line Chemoimmunotherapy in Chronic Lymphocytic Leukemia?
Haematologica
Hematology
Chemoimmunotherapy With GA101 Plus Chlorambucil in Patients With Chronic Lymphocytic Leukemia and Comorbidity: Results of the CLL11 (BO21004) Safety Run-In
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
